Tags |
|
|
Links |
|
|
Digg It - How Would You Handle This?
We have been talking about choosing groups to participate in that meet your needs and goals as a business
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
professional. Once the decision is made on which groups to belong to, then a certain level of participat
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ion is required in order to achieve the individual goals set by the business professional.
Whenever I at
Whenever I at
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
tend a function, I always have a goal of meeting ten people whom I do not already know, and finding out h
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ow I can best help them in their business. What happens, though if, when I enter the function, someone wh
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
o I already know, approaches me and begins a lengthy conversation that could best be handled at a differe
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
nt time and place? How do I break away to complete my goal of meeting ten new people?
This has happened
This has happened
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
to me frequently and I have found this technique to work well. As soon as there is a break in the convers
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
ation, I let the person I am listening to know that I need to excuse myself, because I must meet some new
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
people to accomplish the goal I came to the function for. I usually say what the goal is- to meet 10 new
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
people. I also state that I would be happy to continue our conversation as soon as I have "hit my quota"
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
, ( I always say that with a smile), and also offer to continue the conversation at a later time if neces
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
sary.
The idea that someone would come to a networking function with a specific goal in mind is foreign
The idea that someone would come to a networking function with a specific goal in mind is foreign
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
to many participants. I suggest that you have a goal for all functions that you participate in . It is an
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
easy way to track accomplishments. If my goal is to meet 10 people and I have a certain amount of time t
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
o work with, I know how much time I can devote to each person to accomplish my goal.
There is no reason
There is no reason
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
to walk away from a networking function with unfulfilled goals because someone that couldn't help you acc
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
omplish your goals monopolized your time.
Your goal may be to meet a specific person who you know would
Your goal may be to meet a specific person who you know would
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
be able to help you, if you had a chance to speak with them and build a relationship with them. Next wee
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
k, I'll tell you how to break into "cliques" that may be formed around the person you would like to meet.
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/30129/diggit-How-Would-You-Handle-This.html">How Would You Handle This?</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/30129/diggit-How-Would-You-Handle-This.html]How Would You Handle This?[/url]
Related Articles:
MANAGING CRISIS; when you're too good at it
Bookmark it:
|